Kabiven Peripheral

Composition, structure and packing

Kabiven peripheral is available in three-chamber bag. The bag contains a volume of 1920 ml: rr dextrose 11% - 1180 ml, p-p Vamin 1918 Novum - 400 ml Intralipid 20% - 340 ml. Emulsion for infusion, which is formed after mixing the contents of the three chambers three-chamber bag, homogeneous, white.

The composition of the emulsion after mixing the contents of 3 chambers (1920 ml):

Fat 85 g, including: purified soybean oil 68 g;
purified egg phospholipids 4.1 g glycerol (anhydrous) 7.5 g;

Carbohydrates, including: Dextrose monohydrate 143 g, which corresponds to the content of anhydrous dextrose, 130 g;

Amino acids 57 g, including: alanine 6.4 g;
arginine, 4.5 g;
aspartic acid, 1.4 g;
valine, 2.9 g;
histidine, 2.7 g;
glycine, 3.2 g;
glutamic acid 2.2 g;
isoleucine 2.2 g;
leucine, 3.2 g;
lysine hydrochloride 4.5 g, 4.5 g, which corresponds to the content of lysine 3.6 g;
methionine 2.2 g;
Proline 2.7 g Serine 1.8 g;
Tyrosine 92 mg;
threonine, 2.2 g;
tryptophan 760 mg;
Phenylalanine 3.2 PM

Electrolytes: calcium chloride x 2H2O 390 mg, which corresponds to the contents of calcium chloride, 300 mg sodium glycerophosphate (anhydrous) 2 g magnesium sulfate x 7H2O 1.3 g, which corresponds to the content of magnesium sulfate 640 mg of potassium chloride, 2.4 g sodium acetate x 3N2O 3.3 g, which corresponds content of sodium acetate, 2 g equivalent content:
Na + 43 mmol;
K + 32 mmol;
Mg2 + 5.3 mmol;
Ca2 + 2.7 mmol;
phosphate 14 mmol;
sulphate 5.3 mmol;
Cl-62 mmol;
CH3COO-52 mM;
nitrogen, 7.2 g;
osmolality approximately 830 mOsm per kg;
water osmolarity of 750 mOsm / l;
pH 5.4-5.8 energy: total 1400 kkal/1920 ml, nonprotein 1200 kkal/1920 ml. Excipients: Water d / and.

Clinico-pharmacological group: The preparation for parenteral nutrition - a solution of amino acids, fats, carbohydrates, electrolytes.

Pharmacological action

Tool for parenteral nutrition. The action of the drug is determined by the pharmacological activity of its components. Vamin 1918 Novum intended for parenteral nutrition in patients with different pathologies with increased protein requirements, when enteral feeding is ineffective or impossible. Intralipid used for parenteral nutrition as a source of energy and essential fatty acids. Intralipid is shown in patients with deficiency of essential fatty acids, incapable of self-fill the normal balance of essential fatty acids by oral administration. Intralipid contains refined soybean oil, emulsified with purified egg phospholipids. The size of lipid globules and biological properties Intralipida similar to the characteristics of endogenous chylomicrons.

In contrast to chylomicrons Intralipid does not contain cholesterol esters and apolipoprotein B, and phospholipid content is higher. Dextrose (glucose) is an indispensable source of quick release energy required, including and for the metabolism of amino acids.

With the simultaneous infusion of dextrose and lipid emulsion reduces the risk of thrombosis (because of lower osmolarity of dextrose and a dilution), which always exists infusion of hypertonic solutions in the peripheral veins.


Intralipid is derived from the blood flow in the same way as the chylomicrons. Exogenous lipid particles are mainly hydrolyzed in the blood and trapped LDL-receptors in the liver and peripheral tissues. Elimination rate is determined by the composition of lipid particles, clinical condition and nutritional status of the patient, as well as the rate of infusion.

The maximum clearance Intralipida fasting equivalent to 3.8 +1.5 g triglycerides / kg / day. Elimination rate and oxidation depend on the clinical condition of the patient: excretion and oxidation are accelerated in sepsis and after trauma, and, conversely, slowing renal failure and hypertriglyceridemia.

Pharmacokinetic characteristics of amino acids and electrolytes, imposed by the in / infusions, such as when entering a normal diet. However, the amino acid food proteins first enter the portal vein of the liver, and only then into the systemic circulation, whereas the amino acids introduced into the vein, directly into the systemic circulation.

Pharmacokinetic characteristics of dextrose (glucose), introduced by infusion, the same as when she entered with the usual food.

parenteral nutrition of adults and children aged 2 years and older, when oral or enteral nutrition is impossible, insufficient or contraindicated.

Dosage regimen

The drug is introduced into / in the drip. Kabiven peripheral has osmolarity of 750 mOsm / l, and therefore the drug can be introduced for adults and children in the peripheral or central veins. Infusion can continue as long as required by the clinical condition of the patient, based on the daily requirement of glucose, lipids and amino acids. Dose and infusion rate determined by the patient's ability to remove lipids and metabolize glucose.

Kabiven peripheral comes in bags in three sizes, designed for patients with normal, moderately increased or reduced demand for nutrients. For a full parenteral nutrition may need to add vitamins, electrolytes and trace elements. The dose should be selected individually, and the choice of the bag should take into account the patient's condition, body weight and the need for nutrients. In patients with obesity dose should be established on the basis of ideal body weight.

In patients with moderate or severe catabolic stress, with or without malnutrition, the need for amino acids is 1-2 g / kg / day, about the need for nitrogen 0.15-0.3 g / kg / day. The demand for energy is 30-50 kcal / kg / day. This corresponds to 40 ml / kg / day.

Patients without catabolic stress the need for amino acids is 0.7-1 g / kg / day, which is approximately equal to the need for nitrogen 0.1-0.15 g / kg / day. The demand for energy is 20-30 kcal / kg / day. This corresponds to 27-40 ml of peripheral Kabivena 1 kg of body weight per day. The maximum daily dose.

Adults - 40 ml / kg / day. This is equal to 1 bag (maximum size) for a patient weighing 64 kg, and ensures the supply of 0.96 g amino acids / kg / day (0.16 g nitrogen / kg / day), 25 kcal / kg / day non-protein energy, 2.7 g dextrose / kg / day and 1.4 g lipid / kg / day.

For children aged 2-10 years infusion should be started with low doses (14-28 ml / kg, which corresponds to the daily intake of fats, amino acids and glucose, respectively 0.49-0.98 g / kg, 0.34-0.67 g / kg and 0.95- 1.9 g / kg), and the dose should be increased to 10-15 ml / kg / day, maximum of 40 ml / kg / day.

In children older than 10 years can apply the same dose as in adults. Rate of infusion rate of infusion should not exceed 3.7 ml / Kg / h, which corresponds to a dose of dextrose, amino acids and lipids, respectively, 0.25 g / kg / h, 0.09 g / kg / hr and 0.13 g / kg / h. The recommended duration of infusion of peripheral Kabivena is 12-24 hours

Instructions for using three-chamber bag
Remove the outer package, tearing it in place of the notch and pulling it along the bag.
Thumb and index fingers of both hands firmly to take up sides over the middle of the bag retainer that separates the chambers 1 and 2. Pull the walls of the bag in hand and fully open the lock.
Similarly, open the lock between chambers 2 and 3. Stir the contents, turning the bag several times.
If necessary, the introduction of additives (with a known compatibility, for example, preparations of vitamins, trace elements) to wipe the membrane inlet antiseptic.
Put the bag on the table, holding the base of the inlet, fully enter the needle through the center of the membrane and enter the supplement (with a known compatibility). Before the introduction of other additives and mix thoroughly, turning the bag several times.
Remove the cap from the needle infusion system, holding the ring between thumb and forefinger and pulling the ring up. Infusion system to be used without access to air or to block access to the air system, with access of air.
Put the bag on a flat surface. Hold the bag outlet up fully enter the needle through the membrane, if necessary, turning and pushing her. To provide secure needle it should be implemented fully.
The bag should be hung on the rack and carry out the instructions to the infusion system and infusion pump. Another way to open the latches: to put the bag on a flat surface and roll it from the pen until the latches will not engage. Stir the contents, turning the sack several times.

Side effect

Allergic reactions: anaphylactic reaction, fever, chills, tremors, skin rash, urticaria.
On the part of the respiratory system: changes in breathing (tachypnea).
Since the cardiovascular system: the reduction or increase blood pressure.
On the part of the digestive system: increased activity of liver enzymes, abdominal pain.
On the part of the hemopoietic system: hemolysis, reticulocytosis. Local reactions: thrombophlebitis when infused into peripheral veins.

Other: headache, priapism. With the right introduction of side effects developing extremely rare.

marked hyperlipidemia;
marked hepatic impairment;
expressed by the clotting of blood;
inborn errors of metabolism of amino acids;
renal failure, severe in the absence of hemodialysis or hemofiltration;
acute phase of shock;
hyperglycemia, which requires the introduction of insulin in a dose of more than 6 IU / h;
pathologically increased plasma concentration of any constituent of the preparation of electrolytes;
General contraindications to infusion therapy: acute pulmonary edema, hyperhydration, decompensated heart failure and hypotonic dehydration;
unstable states (including post-traumatic condition, uncompensated diabetes mellitus, myocardial infarction in the acute stage, decompensated metabolic acidosis, severe sepsis and hyperosmolar coma);
hypersensitivity to egg and soybean proteins, or to any subsidiary components.

Precautions should be used drug in violation of lipid metabolism due to renal failure, diabetes mellitus, pancreatitis, liver problems, hypothyroidism (with hypertriglyceridemia), or sepsis.

With the introduction of peripheral Kabivena patients with such disorders need careful control of the concentration of TG in plasma.

Pregnancy and lactation

Special Security Studies of peripheral Kabivena during pregnancy and lactation was conducted. Before the appointment Kabivena peripheral during pregnancy and lactation should carefully evaluate the potential benefit of therapy for the mother and the potential risk to the fetus or infant.

Application for violations of liver function

Contraindications: marked hepatic impairment;

Application for violations of renal function

Contraindications: renal failure, severe in the absence of hemodialysis or hemofiltration


In applying the drug should be monitored by the ability of lipid removal by measuring the level of TG in plasma 5-6 h after the last reception of fats. The concentration of TG in plasma during infusion should not exceed 3 mmol / liter.

Fat overload syndrome may occur at recommended rate of infusion if the patient's clinical condition changes drastically and develops severe renal or hepatic insufficiency. It should carefully calculate the amount of the introduced drug, which should be adjusted in accordance with the water balance and nutritional status of the patient. Each container is intended for single use. Marked disorders of electrolyte and water balance should be corrected before the start of infusion.

In the early infusion required monitoring of patients. Since any infusion into the central vein is accompanied by an increased risk of infection during the catheter or the handling of them should abide by strict rules of asepsis to avoid infection. Should regularly monitor the concentration of glucose and electrolytes in blood plasma and plasma osmolarity, water balance, AAR and the activity of liver enzymes. With prolonged administration of lipids should be monitored cellular composition of blood and blood clotting parameters.

In patients with renal insufficiency should be closely monitored balance of phosphate and potassium in order to avoid the development of hyperphosphataemia and hyperkalaemia. Number of additional electrolytes should be determined by regular monitoring of their concentration, taking into account the clinical condition of the patient. This preparation is a lack of vitamins and minerals.

To fill them recommended Vitalipid H adult or child Vitalipid H, Soluvit H Addamel N. When any signs and symptoms of allergic reactions infusion should be stopped immediately. The presence of lipids in peripheral Kabivene can modify the results of some laboratory tests (eg, the concentration of bilirubin, activity of LDH, hemoglobin oxygen saturation), if the blood sample was obtained until a sufficient removal of lipids from the bloodstream.

The majority of patients entered lipids appear after 5-6 h. In / in the introduction of amino acids may be accompanied by increased renal excretion of trace elements, especially zinc. Patients requiring long-term in / in nutrition, may need supplementation of trace elements. We strongly depleted patients beginning total parenteral nutrition can cause a shift of water balance, leading to pulmonary edema and congestive heart failure.

In addition, within 24-48 h in blood plasma can see the decline of the concentration of potassium, phosphorus, magnesium and water-soluble vitamins. It is recommended to start parenteral nutrition slowly with careful monitoring and appropriate correction of fluid, electrolytes, vitamins and trace elements. Kabiven peripheral should not be injected through a catheter in conjunction with blood or blood products. Patients with hyperglycemia may need insulin. Venous catheter through which introduces complete parenteral nutrition, not recommended for use in / introduction of other fluids and drugs. Any remainder of the open container must be destroyed.

Use in Pediatrics

Kabiven peripheral is designed primarily for patients older than 2 years.

In children under 2 years Kabiven peripheral can be used only according to the life in the absence of special adapted amino acid solution containing taurine (Aminova infante). Premature infants and children with low birth weight may have impaired metabolism of fats. Should closely monitor the concentration of TG.


Symptoms: due to violations of the ability of removing fat may develop fat overload syndrome - hyperlipidemia, fever, hepatosplenomegaly, anemia, leukopenia, thrombocytopenia, coagulopathy and coma. Treatment: the cessation of lipid infusion, symptomatic therapy.

Drug Interactions

In therapeutic doses of heparin causes a transient release of lipoprotein lipase into the bloodstream, which may lead initially to increased lipolysis in the blood plasma, and then to a transient decrease in TG clearance. Insulin may also affect the activity of lipase, but data on its adverse impact on the therapeutic efficacy of the drug available.

Vitamin K1, contained in soybean oil, is an antagonist of coumarin derivatives, and therefore recommends careful monitoring of blood clotting in patients receiving these drugs. Kabiven peripherals can be mixed only with those drugs and the nutrient solution, which confirmed compatibility with, for example: Vitalipid H adult and children's Vitalipid N; Soluvit N; Addamel H; Dipeptiven. Mixing solutions should be carried out in aseptic conditions.

Terms and Conditions of storage

The drug should be stored out of reach of children at or above 25 ° C Do not freeze. Shelf life of the drug in the outer bag - 2 years. After the disclosure of catches and mixing of three solutions to a mixture of compatible additives can be added through the inlet. After the disclosure of fixatives chemical and physical stability of the mixed content of the three chambers maintained for 24 h at 25 ° C.

To ensure the microbiological safety of the mixture should be used immediately after the introduction of additives. If the mixture is not used immediately, then, subject to the introduction of aseptic additives, emulsion mixture can be stored up to 6 days at 2 ° to 8 ° C, then the mixture should be used within 24 hours